Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical challenges presented by three simultaneous solid tumors.

Y G Lin1, M Deavers, F Sasan

  • 1Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Division of Gynecologic Oncology, Lyndon Baines Johnson General Hospital, Houston, TX 77230-1439, USA.

Gynecologic Oncology
|October 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancer.

Breast (Edinburgh, Scotland)·2026
Same author

The organic acid environmental capacity of mangrove ecosystem in Dongzhai harbor, Hainan, China.

Marine pollution bulletin·2024
Same author

Correction to: Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?

Annals of surgical oncology·2020
Same author

Merkel Cell Carcinoma Outcomes: Does AJCC8 Underestimate Survival?

Annals of surgical oncology·2020
Same author

[A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia].

Zhonghua yi xue za zhi·2017
Same author

Cognitive Schemas in Social Perception.

Multivariate behavioral research·2016
Same journal

Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

Gynecologic oncology·2026
Same journal

Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasia.

Gynecologic oncology·2026
Same journal

Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

Gynecologic oncology·2026
Same journal

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

Gynecologic oncology·2026
Same journal

A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.

Gynecologic oncology·2026
Same journal

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Gynecologic oncology·2026
See all related articles

This case report details a rare instance of simultaneous cervical, appendiceal, and kidney cancers in one patient. Multidisciplinary care is crucial for managing multiple primary tumors effectively.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Simultaneous occurrence of multiple primary cancers is uncommon and poses significant management challenges.
  • The co-presentation of cervical carcinoma, renal cell carcinoma, and appendiceal carcinoma is unprecedented in medical literature.

Observation:

  • A 57-year-old female patient was diagnosed with cervical cancer.
  • Further investigations revealed concurrent diagnoses of mucinous appendiceal carcinoma and clear cell renal cell carcinoma.
  • The patient underwent surgical treatment for all three malignancies.

Findings:

  • One year post-surgery, the patient shows no evidence of disease recurrence.
  • The patient's nutritional status has shown continuous improvement following treatment.

Related Experiment Videos

Implications:

  • Optimal management of simultaneous tumors necessitates a creative, multidisciplinary team approach.
  • Sequential treatment strategies for multiple primary tumors can be complicated by major surgeries and may compromise curative outcomes.
  • Coordinated, multidisciplinary treatment planning is essential for improving patient prognosis.